Jennifer S. Ford
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jennifer S. Ford has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Emily S. Tonorezos
Department of Medicine, Weill Cornell Medical College, New York, NY
10 shared publications - Aaron McDonald
St. Jude Children’s Research Hospital 7 Department of Epidemiology and Cancer Control Memphis, Tennessee
9 shared publications - Charles A. Sklar
Memorial Sloan Kettering Cancer Center, New York, New York. 1
9 shared publications - Chaya S. Moskowitz
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
9 shared publications - Danielle Novetsky Friedman
Departments of Pediatrics and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
9 shared publications - Gregory T. Armstrong
Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital , Memphis, TN
9 shared publications
Latest Publications
- Open Access
- 22 August 2026
- Published by Springer Nature in Cancer Causes & Control
- Vol. 37 (9)
“I never thought to bring them up to the doctor”: examining symptom appraisal, help-seeking behaviors, and diagnostic delays among young adults with cancer
Purpose: Cancer incidence is rising among young adults (20–39 years), and it is one of the top five causes of death for this age group. Young adults often experience longer delays in diagnosis than children and older adults, which negatively impacts survival and quality of life. Communication interventions might help reduce these delays, but understanding the factors driving delays is crucial for developing effective strategies. Methods: We conducted semi-structured interviews with 30 young adults diagnosed with cancer to explore factors contributing to delays across three intervals: symptom appraisal, help-seeking, and diagnostic. Interviews were conducted in January and February 2023 and analyzed using template analysis by three independent coders. Results: Most young adults misattributed symptoms to stress, lifestyle, or minor issues, and thus delayed seeking medical evaluation. Many used online information to inform care-seeking decisions but encountered content that minimized symptom severity or offered unclear guidance. Upon seeking care, several young adults had to self-advocate for diagnostic testing after providers initially dismissed their concerns. Conclusion: These patterns highlight potentially modifiable targets for future communication interventions. Strategies to improve young adults’ awareness of potential cancer symptoms, address misconceptions about cancer risk, and promote timely care-seeking are warranted. Efforts should also focus on improving the quality of online symptom information and equipping young adults with tools to communicate more effectively with providers. While systemic changes are also needed, individual-level communication campaigns could help shorten time to diagnosis and improve outcomes for young adults with cancer.
- 22 August 2026
- Published by Springer Nature in Cancer Causes & Control
- Vol. 37 (9)
Open Access“I never thought to bring them up to the doctor”: examining symptom appraisal, help-seeking behaviors, and diagnostic delays among young adults with cancer
Purpose: Cancer incidence is rising among young adults (20–39 years), and it is one of the top five causes of death for this age group. Young adults often experience longer delays in diagnosis than children and older adults, which negatively impacts survival and quality of life. Communication interventions might help reduce these delays, but understanding the factors driving delays is crucial for developing effective strategies. Methods: We conducted semi-structured interviews with 30 young adults diagnosed with cancer to explore factors contributing to delays across three intervals: symptom appraisal, help-seeking, and diagnostic. Interviews were conducted in January and February 2023 and analyzed using template analysis by three independent coders. Results: Most young adults misattributed symptoms to stress, lifestyle, or minor issues, and thus delayed seeking medical evaluation. Many used online information to inform care-seeking decisions but encountered content that minimized symptom severity or offered unclear guidance. Upon seeking care, several young adults had to self-advocate for diagnostic testing after providers initially dismissed their concerns. Conclusion: These patterns highlight potentially modifiable targets for future communication interventions. Strategies to improve young adults’ awareness of potential cancer symptoms, address misconceptions about cancer risk, and promote timely care-seeking are warranted. Efforts should also focus on improving the quality of online symptom information and equipping young adults with tools to communicate more effectively with providers. While systemic changes are also needed, individual-level communication campaigns could help shorten time to diagnosis and improve outcomes for young adults with cancer.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Table S1. Baseline characteristics of participants compared to non-participants.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Table S1. Baseline characteristics of participants compared to non-participants.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Methods S1 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Methods S1 is the EQUAL study protocol with details of intervention and control group materials.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods S1 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Methods S1 is the EQUAL study protocol with details of intervention and control group materials.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Data from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Background:Obesity is prevalent in childhood cancer survivors and interacts with cancer treatments to potentiate risk for cardiovascular (CV) death. We tested a remote weight-loss intervention trial that was effective among adults with CV risk factors in a cohort of adult survivors of childhood acute lymphoblastic leukemia (ALL) with overweight/obesity.Methods:In this phase III efficacy trial, survivors of ALL enrolled in the Childhood Cancer Survivor Study with a body mass index ≥25 kg/m2 were randomized to a remotely delivered weight-loss intervention versus self-directed weight loss, stratified by history of cranial radiotherapy. The primary endpoint was the difference in weight loss at 24 months in an intent-to-treat analysis. Analyses were performed using linear mixed-effects models.Results:Among 358 survivors (59% female; median attained age: 37 years; IQR: 33–43 years), the baseline mean (SD) weight was 98.6 kg (24.0) for the intervention group (n = 181) and 94.9 kg (20.3) for controls (n = 177). Adherence to the intervention was poor; 15% of individuals in the intervention group completed 24/30 planned coaching calls. Weight at 24 months was available for 274 (77%) participants. After controlling for cranial radiotherapy, sex, race/ethnicity, and age, the mean (SE) change in weight from baseline to 24 months was −0.4 kg (0.8) for the intervention group and 0.2 kg (0.6) for control participants (P = 0.59).Conclusions:A remote weight-loss intervention that was successful among adults with CV conditions did not result in significant weight loss among adult survivors of childhood ALL.Impact:Future interventions in this population must be tailored to the unique needs of survivors to encourage engagement and adherence.See related In the Spotlight, p. 1147
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Background:Obesity is prevalent in childhood cancer survivors and interacts with cancer treatments to potentiate risk for cardiovascular (CV) death. We tested a remote weight-loss intervention trial that was effective among adults with CV risk factors in a cohort of adult survivors of childhood acute lymphoblastic leukemia (ALL) with overweight/obesity.Methods:In this phase III efficacy trial, survivors of ALL enrolled in the Childhood Cancer Survivor Study with a body mass index ≥25 kg/m2 were randomized to a remotely delivered weight-loss intervention versus self-directed weight loss, stratified by history of cranial radiotherapy. The primary endpoint was the difference in weight loss at 24 months in an intent-to-treat analysis. Analyses were performed using linear mixed-effects models.Results:Among 358 survivors (59% female; median attained age: 37 years; IQR: 33–43 years), the baseline mean (SD) weight was 98.6 kg (24.0) for the intervention group (n = 181) and 94.9 kg (20.3) for controls (n = 177). Adherence to the intervention was poor; 15% of individuals in the intervention group completed 24/30 planned coaching calls. Weight at 24 months was available for 274 (77%) participants. After controlling for cranial radiotherapy, sex, race/ethnicity, and age, the mean (SE) change in weight from baseline to 24 months was −0.4 kg (0.8) for the intervention group and 0.2 kg (0.6) for control participants (P = 0.59).Conclusions:A remote weight-loss intervention that was successful among adults with CV conditions did not result in significant weight loss among adult survivors of childhood ALL.Impact:Future interventions in this population must be tailored to the unique needs of survivors to encourage engagement and adherence.See related In the Spotlight, p. 1147
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Table S2. Secondary weight loss measures among participants in the EQUAL Study.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Table S2. Secondary weight loss measures among participants in the EQUAL Study.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Table S1. Baseline characteristics of participants compared to non-participants.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Table S1. Baseline characteristics of participants compared to non-participants.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Table S2. Secondary weight loss measures among participants in the EQUAL Study.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Table S2. Secondary weight loss measures among participants in the EQUAL Study.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Methods S1 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Methods S1 is the EQUAL study protocol with details of intervention and control group materials.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods S1 from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Supplementary Methods S1 is the EQUAL study protocol with details of intervention and control group materials.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Data from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Background:Obesity is prevalent in childhood cancer survivors and interacts with cancer treatments to potentiate risk for cardiovascular (CV) death. We tested a remote weight-loss intervention trial that was effective among adults with CV risk factors in a cohort of adult survivors of childhood acute lymphoblastic leukemia (ALL) with overweight/obesity.Methods:In this phase III efficacy trial, survivors of ALL enrolled in the Childhood Cancer Survivor Study with a body mass index ≥25 kg/m2 were randomized to a remotely delivered weight-loss intervention versus self-directed weight loss, stratified by history of cranial radiotherapy. The primary endpoint was the difference in weight loss at 24 months in an intent-to-treat analysis. Analyses were performed using linear mixed-effects models.Results:Among 358 survivors (59% female; median attained age: 37 years; IQR: 33–43 years), the baseline mean (SD) weight was 98.6 kg (24.0) for the intervention group (n = 181) and 94.9 kg (20.3) for controls (n = 177). Adherence to the intervention was poor; 15% of individuals in the intervention group completed 24/30 planned coaching calls. Weight at 24 months was available for 274 (77%) participants. After controlling for cranial radiotherapy, sex, race/ethnicity, and age, the mean (SE) change in weight from baseline to 24 months was −0.4 kg (0.8) for the intervention group and 0.2 kg (0.6) for control participants (P = 0.59).Conclusions:A remote weight-loss intervention that was successful among adults with CV conditions did not result in significant weight loss among adult survivors of childhood ALL.Impact:Future interventions in this population must be tailored to the unique needs of survivors to encourage engagement and adherence.See related In the Spotlight, p. 1147
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study
Background:Obesity is prevalent in childhood cancer survivors and interacts with cancer treatments to potentiate risk for cardiovascular (CV) death. We tested a remote weight-loss intervention trial that was effective among adults with CV risk factors in a cohort of adult survivors of childhood acute lymphoblastic leukemia (ALL) with overweight/obesity.Methods:In this phase III efficacy trial, survivors of ALL enrolled in the Childhood Cancer Survivor Study with a body mass index ≥25 kg/m2 were randomized to a remotely delivered weight-loss intervention versus self-directed weight loss, stratified by history of cranial radiotherapy. The primary endpoint was the difference in weight loss at 24 months in an intent-to-treat analysis. Analyses were performed using linear mixed-effects models.Results:Among 358 survivors (59% female; median attained age: 37 years; IQR: 33–43 years), the baseline mean (SD) weight was 98.6 kg (24.0) for the intervention group (n = 181) and 94.9 kg (20.3) for controls (n = 177). Adherence to the intervention was poor; 15% of individuals in the intervention group completed 24/30 planned coaching calls. Weight at 24 months was available for 274 (77%) participants. After controlling for cranial radiotherapy, sex, race/ethnicity, and age, the mean (SE) change in weight from baseline to 24 months was −0.4 kg (0.8) for the intervention group and 0.2 kg (0.6) for control participants (P = 0.59).Conclusions:A remote weight-loss intervention that was successful among adults with CV conditions did not result in significant weight loss among adult survivors of childhood ALL.Impact:Future interventions in this population must be tailored to the unique needs of survivors to encourage engagement and adherence.See related In the Spotlight, p. 1147
- 24 July 2024
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 31 (6) , 819-832
Effective Interventions for Idiopathic Chronic Pelvic Pain: A Systematic Review
- 24 July 2024
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 31 (6) , 819-832
Effective Interventions for Idiopathic Chronic Pelvic Pain: A Systematic Review